(2S,4R)-N-[(1S)-1-(4-chlorophenyl)-3-(methylamino)-3-oxopropyl]-4-hydroxy-1-[(2R)-3-methyl-2-(3-methyl-1,2-oxazol-5-yl)butanoyl]pyrrolidine-2-carboxamide is an advanced ligand specifically engineered for E3 ligase recruitment in targeted protein degradation applications. As an E3 Ligase Ligand, it plays a pivotal role in the design and synthesis of PROTACs (Proteolysis Targeting Chimeras) by selectively binding to ligases such as VHL (von Hippel-Lindau), enabling efficient ubiquitination and subsequent proteasomal degradation of target proteins. This compound facilitates the degradation of disease-related proteins and supports innovative drug discovery efforts, particularly in oncology and neurodegeneration research. Its optimized structure ensures high affinity and specificity, making it suitable for exploring new PROTAC modalities and expanding the toolbox for targeted protein degradation studies.
Structure of 2581826-67-5
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
(2S,4R)-N-[(1S)-1-(4-chlorophenyl)-3-(methylamino)-3-oxopropyl]-4-hydroxy-1-[(2R)-3-methyl-2-(3-methyl-1,2-oxazol-5-yl)butanoyl]pyrrolidine-2-carboxamide is a potent VHL (Von Hippel-Lindau) E3 ligase ligand. VHL is one of the most widely used E3 ligases in PROTAC (Proteolysis Targeting Chimera) research, making this compound valuable for targeted protein degradation strategies. This VHL ligand contains specialized linkable functional groups, enabling flexible conjugation for the design and synthesis of high-efficiency PROTACs.
Mechanism
This VHL ligand selectively binds to the VHL component of the CUL2-VHL E3 ubiquitin ligase complex. Upon binding, it recruits the ligase to proximity of a target protein (delivered via a tethered protein-targeting ligand), which facilitates the transfer of ubiquitin molecules to the target protein. This ubiquitination event signals for the rapid degradation of the targeted protein by the proteasome. The structural features of the ligand allow for robust and stable linker attachment, facilitating optimized PROTAC architectures with enhanced cellular activity and selectivity.
Applications
(2S,4R)-N-[(1S)-1-(4-chlorophenyl)-3-(methylamino)-3-oxopropyl]-4-hydroxy-1-[(2R)-3-methyl-2-(3-methyl-1,2-oxazol-5-yl)butanoyl]pyrrolidine-2-carboxamide is widely used as a VHL E3 ligase binding moiety in PROTAC and targeted degradation research. Common applications include:
• Development of VHL-based PROTACs for selective protein degradation and mechanistic studiesIts suitability for diverse linker attachment ensures compatibility with a wide range of target protein ligands, making it a go-to intermediate for PROTAC development and related targeted protein degradation technologies.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.